5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide

5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide Struktur
357338-64-8
CAS-Nr.
357338-64-8
Englisch Name:
5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
Synonyma:
5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide;Pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-(4-bromophenyl)-4,5,6,7-tetrahydro-N-(1-phenylethyl)-7-(trifluoromethyl)-
CBNumber:
CB62031336
Summenformel:
C22H20BrF3N4O
Molgewicht:
493.32
MOL-Datei:
357338-64-8.mol

5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide Eigenschaften

Siedepunkt:
624.7±55.0 °C(Predicted)
Dichte
1.53±0.1 g/cm3(Predicted)
pka
13.57±0.60(Predicted)

Sicherheit

5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50
Specs --
info@specs.net The Netherlands 6835 70

  • 5-(4-bromophenyl)-N-(1-phenylethyl)-7-(trifluoromethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-2-carboxamide
  • Pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-(4-bromophenyl)-4,5,6,7-tetrahydro-N-(1-phenylethyl)-7-(trifluoromethyl)-
  • 357338-64-8
Copyright 2019 © ChemicalBook. All rights reserved